Aduhelm

Food and Drug Administration
Biotech

Dunn with the FDA: Head of agency's neuroscience unit to depart

Bill Dunn is leaving his post atop the FDA's neuroscience office to pursue new opportunities, according to an email sent to staff.
Max Bayer Feb 27, 2023 12:32pm
Congress at night

Accelerated approval reforms land in Congress' spending bill

Dec 20, 2022 11:31am
crown royalty king queen win

Winner crowned in Alzheimer's contest between Aduhelm and Lilly

Dec 1, 2022 5:30am
Brain Alzheimers question neuro

Eisai makes the case for lecanemab after 2nd patient death

Nov 29, 2022 7:50pm
Alzheimers dementia brain memory loss

J&J's Janssen aims for 'sweet spot' of Alzheimer's R&D

Aug 1, 2022 8:00am
target maze risk risky arrow labyrinth tricky

Roche, Biogen temper Alzheimer's expectations in Q2 calls

Jul 22, 2022 9:07am